| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |